589941106	589941106	CD	B-NP	O
|	|	NN	I-NP	O
GWHH	GWHH	NN	I-NP	O
|	|	NN	I-NP	O
71404272	71404272	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
580029	580029	CD	B-NP	O
|	|	CC	I-NP	O
7/15/1990	7/15/1990	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/12/1990	4/12/1990	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/2/1990	4/2/1990	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56-year-old	56-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
included	include	VBD	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
cigarette	cigarette	NN	B-NP	O
smoking	smoking	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
or	or	CC	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
3/23	3/23	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
sustained	sustain	VBD	B-VP	O
an	an	DT	B-NP	O
IMI	IMI	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
V-tach	V-tach	JJ	B-NP	O
,	,	,	I-NP	O
cardiogenic	cardiogenic	JJ	I-NP	O
shock	shock	NN	I-NP	O
and	and	CC	O	O
Dresler	Dresler	NNP	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
extreme	extreme	JJ	B-NP	O
exertion	exertion	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
retrosternal	retrosternal	JJ	B-NP	O
burning	burning	NN	I-NP	O
which	which	WDT	B-NP	O
radiated	radiate	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
occur	occur	VB	I-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
saw	see	VBD	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Luthi	Luthi	NNP	I-NP	O
who	who	WP	B-NP	O
prescribed	prescribe	VBD	B-VP	O
Isordil	Isordil	NN	B-NP	O
with	with	IN	B-PP	O
much	much	JJ	B-NP	O
decrement	decrement	NN	I-NP	O
in	in	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
8/13	8/13	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
T-4	T-4	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
captopril	captopril	NN	B-NP	O
and	and	CC	I-NP	O
Synthroid	Synthroid	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
6/8	6/8	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Quinaglute	Quinaglute	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
7/4	7/4	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
dizziness	dizziness	NN	B-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
vision	vision	NN	I-NP	O
episodically	episodically	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
discontinuation	discontinuation	NN	I-NP	O
of	of	IN	B-PP	O
captopril	captopril	NN	B-NP	O
and	and	CC	I-NP	O
digoxin	digoxin	NN	I-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
documented	document	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Holter	Holter	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/8/90	6/8/90	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Onlanfalls	Onlanfalls	NNP	B-NP	O
Health	Health	NNP	I-NP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
quinidine	quinidine	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
and	and	CC	I-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
T-4	T-4	NN	B-NP	B-protein
9.2	9.2	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
64	64	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110/90	110/90	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
quinidine	quinidine	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
five	five	CD	I-NP	O
second	second	JJ	I-NP	O
pause	pause	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
DDD	DDD	NN	I-NP	B-DNA
pacer	pacer	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
light-headedness	light-headedness	NN	B-NP	O
without	without	IN	B-PP	O
associated	associate	VBN	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
abated	abate	VBN	I-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
brady	brady	JJ	I-NP	O
or	or	CC	I-NP	O
tachy	tachy	JJ	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
noted	note	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
times	time	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
off	off	JJ	B-NP	O
Isordil	Isordil	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
occurred	occur	VBD	B-VP	O
with	with	IN	B-PP	O
walking	walk	VBG	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
since	since	IN	B-PP	O
restarting	restart	VBG	B-VP	O
Isordil	Isordil	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
monitor	monitor	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
first	first	JJ	I-NP	O
degree	degree	NN	I-NP	O
heart	heart	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
T-4	T-4	NN	I-NP	O
value	value	NN	I-NP	O
was	be	VBD	B-VP	O
9.2	9.2	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Cholecystectomy	Cholecystectomy	NN	B-NP	O
in	in	IN	B-PP	O
1983	1983	CD	B-NP	O
;	;	:	O	O
hypertension	hypertension	NN	B-NP	O
;	;	:	O	O
decreased	decrease	VBN	B-NP	O
T-4	T-4	NN	I-NP	O
;	;	:	O	O
meningitis	meningitis	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
child	child	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
known	know	VBN	B-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
65	65	CD	I-NP	O
;	;	:	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
120/90	120/90	CD	I-NP	O
;	;	:	O	O
temperature	temperature	NN	B-NP	O
97.5	97.5	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
HEENT	HEENT	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	B-protein
2	2	CD	B-NP	I-protein
+	+	SYM	B-ADVP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
upstrokes	upstroke	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
;	;	:	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
;	;	:	O	O
no	no	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
;	;	:	O	O
II/VI	II/VI	LS	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
rubs	rub	NNS	I-NP	O
;	;	:	O	O
PMI	PMI	NN	B-NP	O
nondisplaced	nondisplaced	JJ	I-NP	O
;	;	:	O	O
JVD	JVD	NN	B-NP	O
6	6	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdoman	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	B-protein
scar	scar	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
strong	strong	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
neuro	neuro	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
count	count	NN	I-NP	O
9.4	9.4	CD	I-NP	O
;	;	:	O	O
hematocrit	hematocrit	NN	B-NP	O
42	42	CD	I-NP	O
;	;	:	O	O
platelets	platelet	NNS	B-NP	B-cell_type
390	390	CD	B-NP	O
;	;	:	O	O
sodium	sodium	NN	B-NP	O
143	143	CD	I-NP	O
;	;	:	O	O
potassium	potassium	NN	B-NP	O
5.2	5.2	CD	I-NP	O
;	;	:	O	O
chloride	chloride	NN	B-NP	O
107	107	CD	I-NP	O
;	;	:	O	O
CO2	CO2	NN	B-NP	O
30	30	CD	I-NP	O
;	;	:	O	O
BUN	BUN	NN	B-NP	O
26	26	CD	I-NP	O
;	;	:	O	O
creatinine	creatinine	NN	B-NP	O
1.8	1.8	CD	I-NP	O
;	;	:	O	O
glucose	glucose	NN	B-NP	O
90	90	CD	I-NP	O
;	;	:	O	O
PT	PT	NN	B-NP	O
12.6	12.6	CD	I-NP	O
;	;	:	O	O
PTT	PTT	NN	B-NP	B-protein
29.8	29.8	CD	I-NP	I-protein
;	;	:	O	O
quinidine	quinidine	NN	B-NP	O
level	level	NN	I-NP	O
3	3	CD	I-NP	O
;	;	:	O	O
calcium	calcium	NN	B-NP	O
9.2	9.2	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
revealed	reveal	VBD	B-VP	O
dual	dual	JJ	B-NP	O
chamber	chamber	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
paced	pace	VBN	B-VP	O
;	;	:	O	O
no	no	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
activity	activity	NN	I-NP	O
;	;	:	O	O
rate	rate	NN	B-NP	O
65	65	CD	I-NP	O
;	;	:	O	O
intervals	interval	NNS	B-NP	O
0.16	0.16	CD	B-NP	O
,	,	,	I-NP	O
0.20	0.20	CD	I-NP	O
and	and	CC	I-NP	O
0.50	0.50	CD	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
from	from	IN	B-PP	O
10/7	10/7	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
brady	brady	NN	I-NP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
;	;	:	O	O
intervals	interval	NNS	B-NP	O
0.22	0.22	CD	B-NP	O
,	,	,	I-NP	O
0.12	0.12	CD	I-NP	O
;	;	:	O	O
appropriate	appropriate	JJ	B-NP	O
QTC	QTC	NN	I-NP	O
;	;	:	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
gravity	gravity	NN	I-NP	O
of	of	IN	B-PP	O
1.025	1.025	CD	B-NP	O
,	,	,	O	O
pH	pH	NN	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
urate	urate	NN	B-NP	O
crystals	crystal	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
CHF	CHF	NN	I-NP	B-protein
or	or	CC	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
;	;	:	O	O
cardiomegaly	cardiomegaly	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
dual	dual	JJ	I-NP	O
chamber	chamber	NN	I-NP	O
pacer	pacer	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
Hass	Hass	NNP	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Metteand	Metteand	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Center	Center	NNP	I-NP	O
team	team	NN	I-NP	O
preferred	prefer	VBN	B-VP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
the	the	DT	B-NP	O
Quinidex	Quinidex	NNP	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
observe	observe	VB	B-VP	O
him	him	PRP	B-NP	O
for	for	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
plans	plan	NNS	B-NP	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
Norpace	Norpace	NNP	B-NP	O
if	if	IN	B-SBAR	O
this	this	DT	B-NP	O
occurred	occur	VBD	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
DDD	DDD	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
with	with	IN	B-PP	O
settings	setting	NNS	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
note	note	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
work	work	NN	I-NP	O
up	up	RB	B-ADVP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
revealing	reveal	VBG	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
and	and	CC	I-NP	O
apical	apical	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
location	location	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
old	old	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
and	and	CC	I-NP	O
atenolol	atenolol	NN	I-NP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
regimen	regimen	NN	I-NP	O
without	without	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
Bruce	Bruce	NNP	I-NP	O
ETT	ETT	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
exercised	exercise	VBD	B-VP	O
nine	nine	CD	B-NP	O
minutes	minute	NNS	I-NP	O
stopping	stop	VBG	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
105	105	CD	B-NP	O
;	;	:	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
100/80	100/80	CD	B-NP	O
to	to	TO	B-PP	O
124/78	124/78	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
maximally	maximally	RB	I-VP	O
medicated	medicate	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulse	pulse	NN	I-NP	B-protein
pressure	pressure	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
was	be	VBD	B-VP	O
excellent	excellent	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
maintained	maintain	VBN	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
current	current	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
BUN	BUN	NN	I-NP	O
at	at	IN	B-PP	O
26	26	CD	B-NP	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
1.8	1.8	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
urate	urate	NN	B-NP	O
crystals	crystal	NNS	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
23	23	CD	B-NP	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
1.3	1.3	CD	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
consider	consider	VB	I-VP	O
alkalyzing	alkalyze	VBG	I-VP	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
if	if	IN	B-SBAR	O
we	we	PRP	B-NP	O
suspect	suspect	VBP	B-VP	O
a	a	DT	B-NP	O
true	true	JJ	I-NP	O
urate	urate	NN	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
1/19/90	1/19/90	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ATRIAL	ATRIAL	NN	B-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ASYSTOLE	ASYSTOLE	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

QUESTION	QUESTION	NN	B-NP	O
OF	OF	IN	B-PP	O
URIC	URIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
NEPHROPATHY	NEPHROPATHY	NN	I-NP	O
.	.	.	O	O

TY020/2197	TY020/2197	CD	B-NP	O
LENNY	LENNY	NNP	I-NP	O
C.	C.	NNP	I-NP	O
EHNIS	EHNIS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SH3	SH3	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/7/91	1/7/91	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
7673	7673	CD	B-NP	O
Report	Report	NNP	I-NP	O
:	:	:	O	O
W7151Y0	W7151Y0	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/6/91	4/6/91	CD	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MARIANO	MARIANO	NN	B-NP	O
MYUNG	MYUNG	NN	I-NP	O
,	,	,	O	O
M.D	M.D	NN	B-NP	O
.	.	.	O	O

